Cart
sales@molnova.com
MK-1029
CAS No. 1242273-04-6
MK-1029( MK1029 )
Catalog No. M10979 CAS No. 1242273-04-6
ADC-3680 is a potent, selective prostaglandin D2 receptor (DP2, CRTH2) antagonist for the treatment of asthma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMK-1029
-
NoteResearch use only, not for human use.
-
Brief DescriptionADC-3680 is a potent, selective prostaglandin D2 receptor (DP2, CRTH2) antagonist for the treatment of asthma.
-
DescriptionADC-3680 is a potent, selective prostaglandin D2 receptor (DP2, CRTH2) antagonist for the treatment of asthma.Asthma Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsMK1029
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorProstaglandin Receptor
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number1242273-04-6
-
Formula Weight369.407
-
Molecular FormulaC17H20FNO5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NamePyrido[1,2-a]indole-10-acetic acid, 4-fluoro-6,7,8,9-tetrahydro-7-[(methylsulfonyl)oxy]-, ethyl ester, (7S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Norman P. Expert Opin Investig Drugs. 2014 Jan;23(1):55-66.
molnova catalog
related products
-
Treprostinil
Treprostinil is a potent DP1 IP and EP2 agonist (EC50: 0.6/1.9/6.2 nM).
-
Omidenepag Isopropyl
Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor.
-
Saikogenin D
Saikogenin D is isolated from?Bupleurum chinense, has anti-inflammatory effects. Saikogenin D activates epoxygenases that converts arachidonic acid to epoxyeicosanoids and dihydroxyeicosatrienoic acids, and the metabolites secondarily inhibit prostaglandin E2 (PGE2) production. Saikogenin D results in an elevation of [Ca2+]i due to Ca2+ release from intracellular stores.
